← Back to Search

OPC for Multiple Sclerosis

N/A
Waitlist Available
Research Sponsored by Dorothy Kessler
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
able to participate in coaching in English.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-intervention, 10 weeks, and 2 months post intervention
Awards & highlights

Study Summary

Multiple sclerosis (MS) is a complex disease that negatively impacts a person's ability to participate in a wide range of important and meaningful activities1-4. MS rehabilitation interventions often focus on reducing symptoms, with the assumption that fewer symptoms will lead to improved participation in daily activities5-8. Yet, literature shows that engagement in necessary and desired activities requires more than symptom reduction - it requires people with chronic diseases like MS to apply their knowledge and skills to a complex self-management process9-11 that balances personal values, and activity and environmental demands. Core self-management skills include self-monitoring, problem-solving, decision-making, goal setting, action planning, and the ability to adjust plans when necessary12. Looking beyond MS, coaching interventions have enabled people with stroke13-16, traumatic brain injury17, and Parkinson's disease18, 19 to develop self-management skills and achieve personally meaningful activity goals. Occupational Performance Coaching (OPC) is a well-developed form of coaching that builds competence in core self-management skills and improves participation in daily activities20, 21. The investigator's preliminary work indicates that OPC is an acceptable and feasible intervention for people with MS22. The investigators now must determine if OPC reduces the impact of MS on participation in daily activities and increases the satisfaction of people with MS in performance of personally important daily activities. Therefore, the investigators will conduct a waitlist-control randomized clinical trial (RCT) with 30 adults with MS to determine if receipt of six OPC sessions improves participants' satisfaction with performance in daily activities (primary outcome). The investigators will also examine whether OPC reduces illness intrusiveness (MS impact), improves resilience, and improves autonomy and participation (secondary outcomes).

Eligible Conditions
  • Multiple Sclerosis
  • Quality of Life

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-intervention, 10 weeks, and 2 months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-intervention, 10 weeks, and 2 months post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Canadian Occupational Performance Measure
Secondary outcome measures
Connor-Davidson Resilience Scale-10
Illness Intrusiveness Rating Scale
Impact on Participation and Autonomy Questionnaire
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: OPCExperimental Treatment1 Intervention
Occupational Performance Coaching delivered by telephone
Group II: Waitlist controlActive Control1 Intervention
Intervention provided after post intervention assessment
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Occupational Performance Coaching
2021
N/A
~40

Find a Location

Who is running the clinical trial?

Dorothy KesslerLead Sponsor
Queen's UniversityLead Sponsor
365 Previous Clinical Trials
120,386 Total Patients Enrolled
7 Trials studying Multiple Sclerosis
562 Patients Enrolled for Multiple Sclerosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~9 spots leftby Apr 2025